Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
about
Renal cell carcinoma: Evolving and emerging subtypesMolecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomasGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsTargeted therapies and the treatment of non-clear cell renal cell carcinomaRenal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrumDiagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese populationRenal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features.Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)]PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressivenessMagnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methodsLaparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report.Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literatureDifferential diagnosis of renal tumors with tubulopapillary architecture in children and young adults: a case report and review of literature.Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.Diagnostic approach to eosinophilic renal neoplasmsClinicopathological features of Xp11.2 translocation renal cell carcinoma.TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature.TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumSpectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Adult Patient with Synchronous Gastrointestinal Stromal Tumor and Xp11 Translocation-Associated Renal Cell Carcinoma: A Unique Case Presentation with Discussion and Review of LiteratureMolecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersClinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studiesValidation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleNon-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.Partial nephrectomy for the treatment of translocation renal cell carcinoma.Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.Translocation renal cell carcinomas in adults: a single-institution experience.Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE)Targeting the Met signaling pathway in renal cancer.Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.
P2860
Q24629153-73CCF90C-7677-4C3C-ADE2-54CE2CC2B9F6Q26752945-5D4EA44F-D510-4AF6-AB69-514790E6421BQ26785930-C41A4D20-3078-408C-A34F-51867AE77269Q26995391-641EF74F-A44D-47A0-A74D-ACDC9C485077Q28298351-CAB0AF81-EE83-4698-AFB6-55427EC3EAC5Q31046172-2C9D909A-FDCD-4754-B86C-5CB0158F57B6Q31083638-5669312A-2CAA-4D1E-9822-5766BA5D626BQ33274854-9BF89154-44D5-48F9-A9C6-7BAEA33AC51DQ33655468-EE260B82-48A5-4514-BF80-78D13F400DC4Q33704636-4F2D7193-F302-4FD0-91F4-446D6EEC052AQ33754360-F4AA8191-2CFE-4BD1-B213-DF8B00375BB4Q33761537-65E0EDA1-D886-484E-AB7A-D59148E1FED1Q33967610-81178255-25C7-484E-BCDD-1C9A57CA82B2Q34206517-5BDBE547-5A17-47DF-8A18-CB5557A1FE6EQ34364757-64258E76-8E41-4216-8085-B770E862F5BFQ34448223-5CABD666-2E7A-46F3-B5B9-CDBF9A15CDC2Q34638089-BF153494-F7EB-43F8-80FD-E7E709AFDC15Q35155653-21F20EA9-7269-4958-9916-DC3246534326Q35164815-69357C1A-84E1-49EA-83E3-F0E987EFCB90Q35293660-5F31B853-39A0-4096-AE2B-801E6E28647CQ35632133-AD534DBB-A56A-4A96-9EF6-285311D2F335Q35636323-B6A0AE69-A43A-496F-951F-600D9ACE4F44Q35810625-58683895-3570-436F-8FBC-9F0D02C1861EQ35890513-C8197517-8375-498E-BEAE-CABEC5FFA646Q36001179-EA0FC1CE-B397-473D-A82D-7656D9093E10Q36073126-347943A0-8E5B-43DD-88F9-911A5B4C983DQ36104776-9AD1138E-C1CE-4E63-BC94-77A6B9800FE0Q36151526-0C712BA8-10F1-4016-85E7-9D265DAB7D5EQ36182819-ED1E15A0-1E0C-403D-9022-C9D2C58A8C14Q36205571-4D0D29BF-0982-4DBC-A421-E7D993ED5FE4Q36253663-7688CCAC-8E0F-4BBB-BC74-7AE1A0CEB68CQ36288139-79277701-CF82-48FE-9812-890EA9239F34Q36341169-AF175770-73E2-4BF7-A820-8FC45C3C4EA6Q36481657-C5C7B824-DD43-4C42-8644-C6A2DE40EB07Q36741509-463352DC-3255-4677-A215-CFBE42BEECE3Q37114357-A261A651-A391-4653-BC54-AA60152E486FQ37212701-A1E18AD8-9644-4FEE-84BC-A14B73A17317Q37269202-A62B05B3-CABF-4022-AA6D-FB90A3A3DB42Q37331862-1D1ADD26-6A2C-4E81-8DBD-F57F8BE0F885Q37384169-967D780A-5B60-43A9-95A3-752B8BB1BA2A
P2860
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Xp11 translocation renal cell ...... hologic, and genetic spectrum.
@en
type
label
Xp11 translocation renal cell ...... hologic, and genetic spectrum.
@en
prefLabel
Xp11 translocation renal cell ...... hologic, and genetic spectrum.
@en
P2093
P1476
Xp11 translocation renal cell ...... hologic, and genetic spectrum.
@en
P2093
Angelo M De Marzo
Athanase Billis
David Y Chan
Holger Moch
Jessica Hicks
John N Eble
Josep Lloreta
Michael Goldfischer
Mireya Jimeno
Pedram Argani
P304
P356
10.1097/PAS.0B013E318031FFFF
P407
P50
P577
2007-08-01T00:00:00Z